healthcare News
InflaRx Stock Surges on EU Approval for Sepsis Drug
Shares soared over 36% after the European Commission authorized GOHIBIC for treating critically ill COVID-19 patients.
Sanofi Wins FDA Approval for New Blood Disorder Drug Wayrilz
First-in-class BTK inhibitor for immune thrombocytopenia (ITP) projected to achieve multi-billion dollar peak sales.
Biogen, Eisai Win FDA Nod for At-Home Alzheimer's Drug Leqembi Iqlik
The new subcutaneous autoinjector offers a more convenient weekly maintenance option for patients after initial IV treatment.
Kimberly-Clark to Pay $40.4M Over Defective Surgical Gowns
DOJ settlement resolves criminal charge related to the sale of millions of adulterated MicroCool gowns marketed with false safety claims.
Outlook Therapeutics Stock Plummets 54% on FDA Rejection
Regulator denies approval for the company's wet AMD drug Lytenava for a second time, citing a lack of substantial evidence.
Cognition Therapeutics Prices $30M Offering at 28.5% Discount
Clinical-stage biotech raises capital for Phase 3 trials, but new shares will significantly dilute existing stockholders.
BioXcel Plunges 24% as Financial Fears Eclipse Trial Success
Positive Phase 3 data for its agitation drug IGALMI is overshadowed by mounting concerns over cash burn and weak sales.
UnitedHealth Shares Drop as DOJ Broadens Criminal Probe
Investigation expands to include Optum Rx and physician payments, intensifying scrutiny on the healthcare giant.